Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
SEATTLE, May 28, 2024 -- Atossa Therapeutics, Inc. , today announced support for a new Phase 2 study designed to validate an innovative, artificial intelligence driven, breast cancer risk...